title: UNITAID can address HCV/HIV co-infection.
authors: Tido
authors: T
authors: von Schoen-Angerer
authors: Jennifer
authors: J
authors: Cohn
authors: Tracy
authors: T
authors: Swan
authors: Peter
authors: P
authors: Piot
mesh_terms: D044966:Anti-Retroviral Agents / Q000191:economics / Q000627:therapeutic use; D000998:Antiviral Agents / Q000191:economics / Q000627:therapeutic use; D003906:Developing Countries; D005378:Financial Support; D015658:HIV Infections / Q000188:drug therapy* / Q000453:epidemiology*; D006526:Hepatitis C / Q000188:drug therapy* / Q000453:epidemiology*; D006801:Humans; D016898:Interferon-alpha / Q000191:economics / Q000627:therapeutic use; D007390:International Agencies; D011092:Polyethylene Glycols / Q000191:economics / Q000627:therapeutic use; D011994:Recombinant Proteins / Q000191:economics / Q000627:therapeutic use; D012254:Ribavirin / Q000191:economics / Q000627:therapeutic use
chemical_list: D044966:Anti-Retroviral Agents; D000998:Antiviral Agents; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D012254:Ribavirin; C100416:peginterferon alfa-2a